Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-016511
Filing Date
2017-03-24
Accepted
2017-03-24 16:09:33
Documents
61
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v461243_10k.htm 10-K 508489
2 EXHIBIT 4.3 v461243_ex4-3.htm EX-4.3 20172
3 EXHIBIT 21.1 v461243_ex21-1.htm EX-21.1 3076
4 EXHIBIT 23.1 v461243_ex23-1.htm EX-23.1 2263
5 EXHIBIT 31.1 v461243_ex31-1.htm EX-31.1 12367
6 EXHIBIT 31.2 v461243_ex31-2.htm EX-31.2 12335
7 EXHIBIT 32.1 v461243_ex32-1.htm EX-32.1 4736
8 EXHIBIT 32.2 v461243_ex32-2.htm EX-32.2 4859
  Complete submission text file 0001144204-17-016511.txt   3261061

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT enzn-20161231.xml EX-101.INS 649392
10 XBRL TAXONOMY EXTENSION SCHEMA enzn-20161231.xsd EX-101.SCH 35834
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20161231_cal.xml EX-101.CAL 28890
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20161231_def.xml EX-101.DEF 180826
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20161231_lab.xml EX-101.LAB 240717
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20161231_pre.xml EX-101.PRE 217023
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36435 | Film No.: 17712877
SIC: 2836 Biological Products, (No Diagnostic Substances)